Published Healthcare & Pharmaceuticals Inhibitors Targeting COVID-19 This technology encompasses the development of novel inhibitors for the main protease of SARS-CoV-2. By The University of Arizona
Published Healthcare & Pharmaceuticals Novel Inhibitors for COVID Researchers at UArizona have developed novel inhibitors for the main protease, or Mpro, of SARS-CoV-2, a validated drug target and could be key to the development of antiviral drug By The University of Arizona
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
